ORCID
- Hobart, Jeremy: 0000-0002-2114-7920
DOI
10.1093/ecco-jcc/jjaa104
Publication Date
2020-05-04
Publication Title
Journal of Crohn's and Colitis
ISSN
1873-9946
Embargo Period
2021-05-04
Organisational Unit
Peninsula Medical School
Recommended Citation
Lin, S., Green, H., Hendy, P., Heerasing, N., Chanchlani, N., Hamilton, B., Walker, G., Heap, G., Hobart, J., Martin, R., Coles, A., Irving, P., Chung-Faye, G., Cummings, J., Lytvyak, E., Andersen, V., Wood, A., Tyrrell, J., Beaumont, R., Weedon, M., Kennedy, N., Spiers, A., Harrower, T., Goodhand, J., & Ahmad, T. (2020) 'Clinical features and genetic risk of demyelination following anti-TNF treatment', Journal of Crohn's and Colitis, . Available at: https://doi.org/10.1093/ecco-jcc/jjaa104
